![Thomas Barnes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Barnes
Verkställande Direktör på
Exsilio Therapeutics, Inc.
Profil
Thomas M.
Barnes is President, Chief Executive Officer & Director at Averna Therapeutics, Inc. since 2025.
Dr. Barnes is Entrepreneur Partner at MPM BioImpact LLC since 2020.
Former roles include Chief Executive Officer & Director at Orna Therapeutics, Inc., Director-Genomic Pharmacology at Millennium Pharmaceuticals, Inc., Senior Vice President-Discovery at Ore Pharmaceuticals, Inc., Vice President-Discovery at Sesen Bio, Inc., and Senior VP-Innovative Sciences & eXtellia at Intellia Therapeutics, Inc. Education includes a doctorate from the University of Cambridge conferred in 1991 and an undergraduate degree from The University of Sydney conferred in 1981.
Aktiva positioner av Thomas Barnes
| Företag | Position | Start |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Privat kapitalinvesterare | 2020-02-01 |
Exsilio Therapeutics, Inc.
 Exsilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops genomic medicines | Verkställande Direktör | 2025-01-28 |
Tidigare kända positioner av Thomas Barnes
| Företag | Position | Slut |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Företagsledare/Principal | 2013-01-01 |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Verkställande Direktör | - |
| INTELLIA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Företagsledare/Principal | - |
Ore Pharmaceuticals, Inc.
 Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Företagsledare/Principal | - |
Thomas Barness utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
99
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Exsilio Therapeutics, Inc.
Exsilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops genomic medicines | Health Technology |
